Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Artemis Therapeutics Inc (ATMS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 3,374
  • Shares Outstanding, K 5,150
  • Annual Sales, $ 0 K
  • Annual Income, $ -1,140 K
  • 36-Month Beta 0.73
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.09
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/12/18
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6551 unch
on 09/19/18
0.7651 -14.38%
on 09/11/18
-0.1949 (-22.93%)
since 08/02/18
3-Month
0.6551 unch
on 09/19/18
1.0401 -37.02%
on 06/29/18
-0.3450 (-34.50%)
since 06/19/18
52-Week
0.6501 +0.77%
on 04/11/18
1.7000 -61.46%
on 12/21/17
-0.3449 (-34.49%)
since 08/24/17

Most Recent Stories

More News
Artemis Therapeutics Announces Two Recent Publications Highlighting Artemisone's Activity Against Human Cytomegalovirus And Malaria

SAN DIEGO , June 19, 2018 /PRNewswire/ --  Artemis Therapeutics, Inc . (OTCQB: ATMS), ("Artemis" or the "Company"), a pharmaceutical company developing new therapies for the treatment of infectious...

ATMS : 0.6551 (-13.24%)
Artemis Therapeutics Announces Two Recent Publications Highlighting Artemisone's Activity Against Human Cytomegalovirus And Malaria

Artemis Therapeutics, Inc. (OTCQB: ATMS), ("Artemis" or the "Company"), a pharmaceutical company developing new therapies for the treatment of infectious diseases, including cytomegalovirus and malaria,...

ATMS : 0.6551 (-13.24%)
INKSD : 0.7801 (+1.31%)
Data Presented At The 31st International Conference For Antiviral Research Demonstrate Artemis Therapeutics' Artemisone May Be An Effective Inhibitor Of Human CMV Replication

Artemis Therapeutics, Inc. (OTCQB: ATMS), ("Artemis" or the "Company"), a pharmaceutical company developing new therapies for the treatment of infectious diseases, including cytomegalovirus and malaria,...

ATMS : 0.6551 (-13.24%)
INKSD : 0.7801 (+1.31%)
Data Presented At The 31st International Conference For Antiviral Research Demonstrate Artemis Therapeutics' Artemisone May Be An Effective Inhibitor Of Human CMV Replication

SAN DIEGO , June 12, 2018 /PRNewswire/ --  Artemis Therapeutics, Inc . (OTCQB: ATMS), ("Artemis" or the "Company"), a pharmaceutical company developing new therapies for the treatment of infectious...

ATMS : 0.6551 (-13.24%)
Artemis Therapeutics Announces Additional Patent Issuance For Artemisone For The Treatment Of Viral Infections

SAN DIEGO , April 16, 2018 /PRNewswire/ --  Artemis Therapeutics, Inc . (OTCQB: ATMS), ("Artemis" or the "Company"), a pharmaceutical company developing new therapies for the treatment of life-threatening...

ATMS : 0.6551 (-13.24%)
Artemis Therapeutics Announces Additional Patent Issuance For Artemisone For The Treatment Of Viral Infections

Artemis Therapeutics, Inc. (OTCQB: ATMS), ("Artemis" or the "Company"), a pharmaceutical company developing new therapies for the treatment of life-threatening infectious diseases, today announced the...

ATMS : 0.6551 (-13.24%)
INKSD : 0.7801 (+1.31%)
OTCQX And OTCQB Companies to Present At 2018 ROTH Conference

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market presenting companies...

KSHB : 5.2300 (+3.36%)
EVLLF : 0.8000 (-4.93%)
OPRX : 17.95 (+5.09%)
DMIFF : 0.2630 (+1.94%)
CORVF : 2.4800 (unch)
IMPZY : 0.7400 (-8.07%)
CHPE : 19.2500 (-1.18%)
CBWTF : 0.9700 (-2.63%)
ATMS : 0.6551 (-13.24%)
RSSS : 2.1100 (+2.93%)
FSSN : 0.1350 (-2.17%)
MSRT : 0.1342 (+1.67%)
GPVRF : 0.4125 (+3.12%)
QBIO : 2.8350 (+5.29%)
SNYR : 0.2625 (-2.78%)
ACBFF : 8.4400 (-0.82%)
CVSI : 5.4200 (-5.74%)
RSASF : 0.2400 (+33.78%)
COSM : 5.3000 (+8.16%)
GRWG : 4.1600 (+0.85%)
GTBP : 2.0000 (+1.52%)
ZYXI : 3.1400 (-3.38%)
PURE : 0.6516 (-1.27%)
CXDO : 2.0000 (-11.89%)
BCTXF : 0.0936 (+5.17%)
TAOIF : 0.3000 (-4.21%)
BNOEF : 0.3900 (+2.63%)
NMKEF : 0.5251 (-0.36%)
CNNRF : 5.1145 (-3.32%)
ZEST : 1.1600 (+4.04%)
HEOFF : 0.8374 (-1.48%)
ITHUF : 6.3500 (-2.46%)
COTQF : 0.1436 (-11.74%)
OTCM : 28.7000 (unch)
DCTH : 8.6800 (+55.00%)
AEYE : 8.15 (-7.91%)
VFFIF : 5.6866 (-4.75%)
TITXF : 0.1930 (-1.03%)
NMGRF : 0.2267 (-0.92%)
GLDLF : 0.6600 (+0.99%)
SNNVF : 4.2600 (-17.28%)
IWSY : 1.0080 (-0.20%)
ARTH : 0.4000 (-2.44%)
IRNC : 0.6200 (+21.57%)
PNGZF : 0.1400 (-3.45%)
NTSFF : 0.6513 (+1.58%)
OTCQX And OTCQB Companies to Present At 2018 ROTH Conference

NEW YORK , March 8, 2018 /PRNewswire/ -- OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market...

EVLLF : 0.8000 (-4.93%)
KSHB : 5.2300 (+3.36%)
DMIFF : 0.2630 (+1.94%)
OPRX : 17.95 (+5.09%)
CORVF : 2.4800 (unch)
IMPZY : 0.7400 (-8.07%)
CBWTF : 0.9700 (-2.63%)
CHPE : 19.2500 (-1.18%)
ATMS : 0.6551 (-13.24%)
RSSS : 2.1100 (+2.93%)
FSSN : 0.1350 (-2.17%)
MSRT : 0.1342 (+1.67%)
GPVRF : 0.4125 (+3.12%)
QBIO : 2.8350 (+5.29%)
SNYR : 0.2625 (-2.78%)
ACBFF : 8.4400 (-0.82%)
CVSI : 5.4200 (-5.74%)
COSM : 5.3000 (+8.16%)
RSASF : 0.2400 (+33.78%)
GTBP : 2.0000 (+1.52%)
ZYXI : 3.1400 (-3.38%)
GRWG : 4.1600 (+0.85%)
PURE : 0.6516 (-1.27%)
CXDO : 2.0000 (-11.89%)
BCTXF : 0.0936 (+5.17%)
TAOIF : 0.3000 (-4.21%)
BNOEF : 0.3900 (+2.63%)
NMKEF : 0.5251 (-0.36%)
CNNRF : 5.1145 (-3.32%)
ITHUF : 6.3500 (-2.46%)
HEOFF : 0.8374 (-1.48%)
ZEST : 1.1600 (+4.04%)
COTQF : 0.1436 (-11.74%)
OTCM : 28.7000 (unch)
DCTH : 8.6800 (+55.00%)
AEYE : 8.15 (-7.91%)
TITXF : 0.1930 (-1.03%)
VFFIF : 5.6866 (-4.75%)
NMGRF : 0.2267 (-0.92%)
GLDLF : 0.6600 (+0.99%)
SNNVF : 4.2600 (-17.28%)
IWSY : 1.0080 (-0.20%)
ARTH : 0.4000 (-2.44%)
IRNC : 0.6200 (+21.57%)
PNGZF : 0.1400 (-3.45%)
NTSFF : 0.6513 (+1.58%)
Artemis Therapeutics Receives Orphan Drug Designation From U.S. Food And Drug Administration For Artemisone For The Treatment Of Malaria

Artemis Therapeutics, Inc. (OTCQB: ATMS), ("Artemis" or the "Company"), a pharmaceutical company developing new therapies for the treatment of life-threatening infectious diseases, today announced that...

ATMS : 0.6551 (-13.24%)
INKSD : 0.7801 (+1.31%)
Artemis Therapeutics Appoints Brian M. Culley As Chief Executive Officer

Artemis Therapeutics, Inc. (OTCQB: ATMS), ("Artemis" or the "Company"), a clinical-stage biopharmaceutical company developing new therapies for the treatment and prevention of severe and life-threatening...

ATMS : 0.6551 (-13.24%)
INKSD : 0.7801 (+1.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is in the Top 1%. Long term indicators mostly agree with the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade ATMS with:

Key Turning Points

2nd Resistance Point 0.7883
1st Resistance Point 0.7217
Last Price 0.6551
1st Support Level 0.6218
2nd Support Level 0.5885

See More

52-Week High 1.7000
Fibonacci 61.8% 1.2989
Fibonacci 50% 1.1751
Fibonacci 38.2% 1.0512
Last Price 0.6551
52-Week Low 0.6501

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar